2,514
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Unusual manifestations of giant cell arteritis and granulomatosis with polyangiitis

, , , , , , , , , , , & show all
Pages 94-98 | Received 26 Apr 2019, Accepted 11 Aug 2019, Published online: 30 Aug 2019

References

  • Katsuyama T, Sada KE, Makino H. Current concept and epidemiology of systemic vasculitides. Allergol Int. 2014;63:505–513.
  • Hamidou MA, Moreau A, Toquet C, et al. Temporal arteritis associated with systemic necrotizing vasculitis. J Rheumatol. 2003;30:2165–2169.
  • Nishino H, DeRemee RA, Rubino FA, et al. Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc. 1993;68:115–121.
  • Buttgereit F, Dejaco C, Matteson EL, et al. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315:2442–2458.
  • Quan MV, Frankel SK, Maleki-Fischbach M, et al. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis. BMC Pulm Med. 2018;18:181.
  • Nesher G, Breuer GS. Giant cell arteritis and polymyalgia rheumatica: 2016 update. Rambam Maimonides Med J. 2016;7:e0035.
  • Nesher G, Berkun Y, Mates M, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine. 2004;83:114–122.
  • Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine. 2005;84:269–276.
  • Sun F, Ma S, Zheng W, et al. A retrospective study of Chinese patients with Giant cell arteritis (GCA): clinical features and factors associated with severe ischemic manifestations. Medicine. 2016;95:e3213.
  • Généreau T, Lotholary O, Pottier MA, et al. Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group. Arthritis Rheum. 1999;42:2674–2681.
  • Bornstein G, Barshack I, Koren-Morag N, et al. Negative temporal artery biopsy: predicitive factors for giant cell arteritis diagnosis and alternate diagnoses of patient without arteritis. Clin Rheumatol. 2018;37:2819–2824.
  • Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76–85.
  • Chirinos JA, Tamariz LJ, Lopes G, et al. Large vessel involvement in ANCA-associated vasculitides: report of a case and review of the literature. Clin Rheumatol. 2004;23:152–159.
  • Carels T, Verbeken E, Blockmans D, et al. p-ANCA-associated periaortitis with histological proof of Wegener's granulomatosis: case report. Clin Rheumatol. 2005;24:83–86.
  • Dábague J, Arévalo RM, García-Torres R, et al. Takayasu's arteritis and Wegener's granulomatosis. A coincidental case. Clin Exp Rheumatol. 1995;13:413–414.
  • Shitrit D, Shitrit AB, Starobin D, et al. Large vessel aneurysms in Wegener's granulomatosis. J Vasc Surg. 2002;36:856–858.
  • Bradley JD, Pinals RS, Blumenfeld HB, et al. Giant cell arteritis with pulmonary nodules. Am J Med. 1984;77:135–140.
  • Hassane HH, Beg MM, Siva C, et al. Co-presentation of giant cell arteritis and granulomatosis with polyangiitis: a case report and review of literature. Am J Case Rep. 2018;6:651–655.
  • Ono N, Niiro H, Ueda A, et al. Characteristics of MPO‐ANCA‐positive granulomatosis with polyangiitis: a retrospective multi‐centre study in Japan. Rheumatol Int. 2015;35:555–559.
  • Chen M, Yu F, Zhang Y, et al. Characteristics of Chinese patients with Wegener's granulomatosis with anti‐myeloperoxidase autoantibodies. Kidney Int. 2005;68:2225–2229.